1. Home
  2. VTRS vs BSAC Comparison

VTRS vs BSAC Comparison

Compare VTRS & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$16.97

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Logo Banco Santander - Chile ADS

BSAC

Banco Santander - Chile ADS

HOLD

Current Price

$34.97

Market Cap

16.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
BSAC
Founded
1961
1977
Country
United States
Chile
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
16.3B
IPO Year
2019
2002

Fundamental Metrics

Financial Performance
Metric
VTRS
BSAC
Price
$16.97
$34.97
Analyst Decision
Buy
Hold
Analyst Count
4
3
Target Price
$13.50
$33.00
AVG Volume (30 Days)
9.4M
264.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
3.21%
3.51%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$14,299,900,000.00
N/A
Revenue This Year
$4.41
$37.15
Revenue Next Year
$1.96
$7.52
P/E Ratio
$336.20
$14.40
Revenue Growth
N/A
N/A
52 Week Low
$9.43
$23.71
52 Week High
$18.39
$37.72

Technical Indicators

Market Signals
Indicator
VTRS
BSAC
Relative Strength Index (RSI) 53.24 55.71
Support Level $15.95 $34.89
Resistance Level $17.17 $36.00
Average True Range (ATR) 0.35 0.75
MACD 0.04 0.02
Stochastic Oscillator 75.11 58.53

Price Performance

Historical Comparison
VTRS
BSAC

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: